News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Richard J. Whitley, MD Joins Gilead Sciences, Inc.'s Board of Directors
July 31, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) announced today that Richard J. Whitley, MD has been appointed to the company’s Board of Directors, bringing the number of Directors to 11.
Twitter
LinkedIn
Facebook
Email
Print
People
Gilead Sciences, Inc.
MORE ON THIS TOPIC
IPOs
MapLight Keeps Biopharma’s IPO Flame Alight To Advance Alzheimer’s, Schizophrenia Drugs
September 22, 2025
·
2 min read
·
Tristan Manalac
Gene therapy
Bye Bye Bluebird: Gene Therapy Biotech Emerges From Private Buyout With Rebrand
September 19, 2025
·
2 min read
·
Annalee Armstrong
Layoff Tracker
Arvinas Downsizes by 15% After Punting Pfizer-Partnered Asset
September 19, 2025
·
203 min read
·
BioSpace Editorial Staff
Neurodegenerative disease
VectorY Bets up to $1.2B+ That Shape’s Brain-Penetrant Capsids Are a Fit
September 18, 2025
·
2 min read
·
Dan Samorodnitsky
